Stephen Andrew Welch

Insider Reports History

Location
Louisville, KY
Signature
/s/ Mark Tyndall, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Andrew Welch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mallinckrodt plc EVP & Head of Spec Generics Ordinary Shares 3.63K $37.50 01 Jan 2025 Direct
Mallinckrodt plc EVP & Head of Spec Generics Restricted Stock Units 0 10 Nov 2025 Direct

Insider Reports Filed by Stephen Andrew Welch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
Keenova Therapeutics plc 10 Nov 2025 1 $0 4 12 Nov 2025 EVP & Head of Spec Generics
Mallinckrodt plc 31 Jul 2025 1 $0 4 04 Aug 2025 EVP & Head of Spec Generics
NONE Mallinckrodt plc 01 Jan 2025 3 $0 4 02 Jan 2025 EVP & Head of Spec Generics
NONE Mallinckrodt plc 02 Feb 2024 1 $0 4 06 Feb 2024 EVP & Head of Spec Generics
MNKTQ Mallinckrodt plc 14 Nov 2023 1 $0 4 16 Nov 2023 EVP & Head of Spec Generics
MNK Mallinckrodt plc 17 Aug 2023 1 -$4.06K 4 18 Aug 2023 EVP & Head of Spec Generics
MNK Mallinckrodt plc 30 Jun 2023 1 $0 4 05 Jul 2023 EVP & Head of Spec Generics
MNK Mallinckrodt plc 03 Apr 2023 1 $0 4 05 Apr 2023 EVP & Head of Spec Generics
MNK Mallinckrodt plc 13 Mar 2023 1 $8.48K 4 15 Mar 2023 EVP & Head of Spec Generics
MNK Mallinckrodt plc 14 Dec 2022 1 $0 4 22 Dec 2022 EVP & Head of Spec Generics
MNKPF Mallinckrodt plc 17 Aug 2022 0 $0 3 26 Aug 2022 EVP & Head of Spec Generics